MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high

$0.42

Daily low

$0.35

Price at open

$0.40

52 Week High

$17.38

52 Week Low

$0.16

Market cap

2.1M

Dividend yield

0.00%

Volume

125,524

Avg. volume

1.8M

P/E ratio

-.01

Moleculin Biotech News